HKEX: 6160 - BeiGene, Ltd.

Yield per half year: +22.29%
Sector: Healthcare

BeiGene, Ltd.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 35.42 -100% -124.4 -100%
P/S 57.06 7.59 652.01%
P/BV 5.08 3.68 37.85%
P/FCF -93.59 55.41 -268.92%
Ev/Ebitda -108.51 2.91 -3831.62%
Ev/S 592.74 23.72 2399.38%
Ev/FCF -106.42 63.79 -266.85%
E/P -0.000688 0.0326 -102.11%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-121.71 -11.9 922.64% -222.23 -45.23%
ROE -2.85 5.19 -154.96%
ROA -1.85 3.47 -153.41%
ROIC 0 0 0%
ROS -35.85 -11.49 212.1%
ROCE 0 6.04 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.3933 0.7755 -150.72% -0.7032 -44.07%
Nеt Debt/Ebitda -0.3122 0.0128 -2547.47%
Debt/Ratio 0.1165 0.1229 -5.2%
Debt/Equity 0.7091 0.8001 -11.37%
Debt/Net Income -5.99 1.76 -440.99%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.42 -100% 0 0%
Number of years of dividend growth 0 1.21 -100%
DSI 0 0.563 -100%
Average dividend growth 0 3.2 -100%
Average percentage for 5 years 0 1.82 -100%
Average percentage for payments 0 23.96 -100%
Difference from average difference in sector -2.42
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
-26.2 19.4 -235.05%
Growth impulse Ebitda 5 years 73.18 -44.8 -263.35%
Growth impulse Net Income 5 years -88.06 80.79 -209%
Growth impulse FCF 5 years 93.64 76.43 22.52%
Growth impulse EPS 5 years -96.9 -116.84 -17.07%
IP Score
2.84/10

Similar companies

AIM Vaccine Co., Ltd.

Innovent Biologics, Inc.

Genscript Biotech Corporation

Zai Lab Limited